New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational Study.
Hao Yu WangKe-Fei DouChangdong GuanLihua XieYunfei HuangRui ZhangWeixian YangYongjian WuYuejin YangShubin QiaoRunlin GaoBo XuPublished in: Circulation. Cardiovascular interventions (2022)
inhibitor (mostly clopidogrel) improved both composite and individual efficacy outcomes by reducing ischemic risk, without a concomitant increase in clinically relevant bleeding.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- end stage renal disease
- ejection fraction
- chronic kidney disease
- coronary artery bypass grafting
- newly diagnosed
- atrial fibrillation
- peritoneal dialysis
- prognostic factors
- heart failure
- metabolic syndrome
- adipose tissue
- insulin resistance
- subarachnoid hemorrhage
- oxidative stress
- blood brain barrier